Peter Dudek

President at

Merck Research Ventures

Health Technology

Finance

Consumer Services

Profile

Dr. Peter Dudek is a President at Merck Research Ventures.
He is on the Board of Directors at InduPro, Inc., Caraway Therapeutics, Inc., Tallac Therapeutics, Inc., Mozart Therapeutics, Inc. and Ambagon Therapeutics, Inc. Dr. Dudek was previously employed as a Principal by Wellington Partners GmbH and an Associate by Entrepreneurs Fund Management LLP.
He also served on the board at Xilio Therapeutics LLC.
He received his undergraduate degree from the University of British Columbia and a doctorate degree from the University of Geneva.

Peter Dudek active positions

Companies	Position	Start
Merck Research Ventures Merck Research Ventures Investment ManagersFinance Merck Research invests in companies located globally. The firm targets companies operating in the therapeutics sector. It participates in seed and early stage capital requirements with an investment size of up to USD 25 million. The firm acts as a lead and co-lead investor and takes a seat on the board of directors. It also makes follow-on investments and does not invest in medical devices, diagnostic platforms and digital health.	President	2021-02-28
Ambagon Therapeutics, Inc. Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services	Director/Board Member	2020-06-30
Mozart Therapeutics, Inc. Mozart Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies to cure autoimmune diseases	Director/Board Member	2020-11-30
InduPro, Inc. InduPro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies	Director/Board Member	2022-01-31
Caraway Therapeutics, Inc. Caraway Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company for the treatment of genetically defined neurodegenerative and rare diseases	Director/Board Member	2021-10-31
Tallac Therapeutics, Inc. Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides	Director/Board Member	2021-10-31

All active positions of Peter Dudek

Former positions of Peter Dudek

Companies	Position	End
Xilio Therapeutics LLC Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals	Director/Board Member	2021-01-31
Wellington Partners GmbH Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor.	Private Equity Investor	2018-03-30
Entrepreneurs Fund Management LLP Entrepreneurs Fund Management LLP Investment ManagersFinance Entrepreneurs Fund invests in companies located primarily in Western Europe. The firm targets companies operating in the fields of life sciences and technology. It provides financing from seed to pre-IPO stages with an investment size of EUR 250k – 10 million.	Private Equity Analyst	2015-12-31

See the detail of Peter Dudek's experience

Training of Peter Dudek

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Peter Dudek's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Wellington Partners GmbH Wellington Partners GmbH Investment ManagersFinance Wellington Partners invests in companies located in Germany, Europe and beyond. The firm focuses on life sciences companies. It provides financing for early and growth stage capital requirements with an investments size of EUR 2 - 20 million. It also acts as a lead and co-lead investor.	Finance
University of British Columbia University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Geneva University of Geneva Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Entrepreneurs Fund Management LLP Entrepreneurs Fund Management LLP Investment ManagersFinance Entrepreneurs Fund invests in companies located primarily in Western Europe. The firm targets companies operating in the fields of life sciences and technology. It provides financing from seed to pre-IPO stages with an investment size of EUR 250k – 10 million.	Finance
Merck Research Ventures Merck Research Ventures Investment ManagersFinance Merck Research invests in companies located globally. The firm targets companies operating in the therapeutics sector. It participates in seed and early stage capital requirements with an investment size of up to USD 25 million. The firm acts as a lead and co-lead investor and takes a seat on the board of directors. It also makes follow-on investments and does not invest in medical devices, diagnostic platforms and digital health.	Finance
Caraway Therapeutics, Inc. Caraway Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company for the treatment of genetically defined neurodegenerative and rare diseases	Health Technology
Tallac Therapeutics, Inc. Tallac Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of immunomodulation polynucleotides	Health Technology
Ambagon Therapeutics, Inc. Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Provides biotechnology services	Health Technology
Mozart Therapeutics, Inc. Mozart Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies to cure autoimmune diseases	Health Technology
Xilio Therapeutics LLC Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals	Health Technology
InduPro, Inc. InduPro, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies	Commercial Services